Breast cancer in young women: special considerations in multidisciplinary care

References

• AndersCKJohnsonRLittonJPhillipsMBleyerABreast cancer before age 40 yearsSemin Oncol20093623724919460581
   PubMed Web of Science ®Google Scholar
• AssiHAKhouryKEDboukHKhalilLEMouhieddineTHEl SaghirNSEpidemiology and prognosis of breast cancer in young womenJ Thorac Dis20135S2S823819024
   PubMed Web of Science ®Google Scholar
• GabrielCADomchekSMBreast cancer in young womenBreast Cancer Res20101221221067532
   PubMed Web of Science ®Google Scholar
• DeSantisCHowladerNCroninKAJemalABreast cancer incidence rates in U.S. women are no longer decliningCancer Epidemiol Bio-markers Prev201120733749
   PubMed Web of Science ®Google Scholar
• DeSantisCMaJBryanLJemalABreast cancer statistics, 2013CA Cancer J Clin201464526224114568
   PubMed Web of Science ®Google Scholar
• AndersCKFanCParkerJSBreast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes?J Clin Oncol200829e18e2021115855
   PubMed Web of Science ®Google Scholar
• TichyJRLimEAndersCKBreast cancer in adolescents and young adults: a review with a focus on biologyJ Natl Compr Canc Netw111060107924029122
   PubMed Web of Science ®Google Scholar
• GnerlichJLDeshpandeADJeffeDBSweetAWhiteNMargenthalerJAElevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage diseaseJ Am Coll Surg200920834134719317994
   PubMed Web of Science ®Google Scholar
• AndersCKHsuDSBroadwaterGYoung age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expressionJ Clin Oncol2008263324333018612148
   PubMed Web of Science ®Google Scholar
• de BockGHvan der HageJAPutterHBonnemaJBartelinkHvan de VeldeCJIsolated loco-regional recurrence of breast cancer is more common in young patients and following breast conserving therapy: long-term results of European Organisation for Research and Treatment of Cancer studiesEur J Cancer20064235135616314086
   PubMed Web of Science ®Google Scholar
• WapnirILAndersonSJMamounasEPPrognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trialsJ Clin Oncol2006242028203716648502
   PubMed Web of Science ®Google Scholar
• BharatAAftRLGaoFMargenthalerJAPatient and tumor characteristics associated with increased mortality in young women (< or =40 years) with breast cancerJ Surg Oncol200910024825119330813
   PubMed Web of Science ®Google Scholar
• AlbainKSAllredDCClarkGMBreast cancer outcome and predictors of outcome: are there age differentials?J Natl Cancer Inst Monogr199435427999467
   PubMedGoogle Scholar
• KromanNJensenMBWohlfahrtJMouridsenHTAndersenPKMelbyeMFactors influencing the effect of age on prognosis in breast cancer: population based studyBMJ200032047447810678859
   PubMed Web of Science ®Google Scholar
• KolliasJEllisIOElstonCWBlameyRWClinical and histological predictors of contralateral breast cancerEur J Surg Oncol19992558458910556004
   PubMed Web of Science ®Google Scholar
• HartmanMCzeneKReillyMGenetic implications of bilateral breast cancer: a population based cohort studyLancet Oncol2005637758215925815
   PubMed Web of Science ®Google Scholar
• LeeKDChenSCChanCHIncreased risk for second primary malignancies in women with breast cancer diagnosed at young age: a population-based study in TaiwanCancer Epidemiol Biomarkers Prev2008172647265518843006
   PubMed Web of Science ®Google Scholar
• CuckleHBreast cancer screening by mammography: an overviewClin Radiol19914377802004517
   PubMed Web of Science ®Google Scholar
• FoxcroftLMEvansEBPorterAJThe diagnosis of breast cancer in women younger than 40Breast20041329730615325664
   PubMed Web of Science ®Google Scholar
• HindleWHDavisLWrightDClinical value of mammography for symptomatic women 35 years of age and youngerAm J Obstet Gynecol19991801484149010368495
   PubMed Web of Science ®Google Scholar
• KolbTMLichyJNewhouseJHComparison of the performance of screening mammography, physical examination, and breast US and evaluation of factors that influence them: an analysis of 27,825 patient evaluationsRadiology200222516517512355001
   PubMed Web of Science ®Google Scholar
• MandelsonMTOestreicherNPorterPLBreast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancersJ Natl Cancer Inst2000921081710880551
   PubMed Web of Science ®Google Scholar
• SaslowDBoetesCBurkeWAmerican Cancer Society guidelines for breast screening with MRI as an adjunct to mammographyCA Cancer J Clin200757758917392385
   PubMed Web of Science ®Google Scholar
• PediconiFCatalanoCRoselliAThe challenge of imaging dense breast parenchyma: is magnetic resonance mammography the technique of choice? A comparative study with x-ray mammography and whole-breast ultrasoundInvest Radiol20094441242119448554
   PubMed Web of Science ®Google Scholar
• ChristianMCMcCabeMSKornELAbramsJSKaplanRSFried-manMAThe National Cancer Institute audit of the National Surgical Adjuvant Breast and Bowel Project Protocol B-06N Engl J Med1995333146916747477148
   PubMed Web of Science ®Google Scholar
• VoogdACNielsenMPeterseJLDifferences in risk factors for local and distant recurrence after breast-conserving therapy or mastectomy for stage I and II breast cancer: pooled results of two large European randomized trialsJ Clin Oncol2001191688169711250998
   PubMed Web of Science ®Google Scholar
• NguyenPLTaghianAGKatzMSBreast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapyJ Clin Oncol2008262373237818413639
   PubMed Web of Science ®Google Scholar
• AbdulkarimBSCuarteroJHansonJDeschenesJLesniakDSabriSIncreased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapyJ Clin Oncol292852285821670451
   PubMed Web of Science ®Google Scholar
• FreedmanGMHanlonALFowbleBLAndersonPRNicolaouNRecursive partitioning identifies patients at high and low risk for ipsilateral tumor recurrence after breast-conserving surgery and radiationJ Clin Oncol2002204015402112351599
   PubMed Web of Science ®Google Scholar
• KurtzJMJacquemierJAmalricRWhy are local recurrences after breast-conserving therapy more frequent in younger patients?J Clin Oncol199085915982313329
   PubMed Web of Science ®Google Scholar
• PataniNMokbelKOncological and aesthetic considerations of skin-sparing mastectomyBreast Cancer Res Treat200811139140317965954
   PubMed Web of Science ®Google Scholar
• KasemAMokbelKEvolving role of skin sparing mastectomyWorld J Clin Oncol5333524829848
   PubMedGoogle Scholar
• LeeMCJohJEChauAAxillary staging prior to neoadjuvant chemotherapy: the roles of sentinel lymph node biopsy and axillary ultrasonographyCancer Control1927728523037495
   PubMed Web of Science ®Google Scholar
• HoussamiNCiattoSTurnerRMCodyHS3rdMacaskillPPreoperative ultrasound-guided needle biopsy of axillary nodes in invasive breast cancer: meta-analysis of its accuracy and utility in staging the axillaAnn Surg25424325121597359
   PubMed Web of Science ®Google Scholar
• Cools-LartigueJMeterissianSAccuracy of axillary ultrasound in the diagnosis of nodal metastasis in invasive breast cancer: a reviewWorld J Surg36465422037691
   PubMed Web of Science ®Google Scholar
• OzADemirkazikFBAkpinarMGEfficiency of ultrasound and ultrasound-guided fine needle aspiration cytology in preoperative assessment of axillary lymph node metastases in breast cancerJ Breast Cancer15211722807939
   PubMed Web of Science ®Google Scholar
• ParbhooSLymphoedema in young patients with breast cancerBreast200615Suppl 2S61S6417382865
   PubMedGoogle Scholar
• KingTASakrRPatilSClinical management factors contribute to the decision for contralateral prophylactic mastectomyJ Clin Oncol2921582156421464413
   PubMed Web of Science ®Google Scholar
• YiMHuntKKArunBKFactors affecting the decision of breast cancer patients to undergo contralateral prophylactic mastectomyCancer Prev Res (Phila)310263420647335
   PubMed Web of Science ®Google Scholar
• StuckyCCGrayRJWasifNDueckACPockajBAIncrease in contralateral prophylactic mastectomy: echoes of a bygone era? Surgical trends for unilateral breast cancerAnn Surg Oncol17Suppl 333033720853055
   PubMed Web of Science ®Google Scholar
• McDonnellSKSchaidDJMyersJLEfficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancerJ Clin Oncol2001193938394311579114
   PubMed Web of Science ®Google Scholar
• HartmannLCSellersTASchaidDJEfficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriersJ Natl Cancer Inst2001931633163711698567
   PubMed Web of Science ®Google Scholar
• PeraltaEAEllenhornJDWagmanLDDagisAAndersenJSChuDZContralateral prophylactic mastectomy improves the outcome of selected patients undergoing mastectomy for breast cancerAm J Surg200018043944511182394
   PubMed Web of Science ®Google Scholar
• HerrintonLJBarlowWEYuOEfficacy of prophylactic mastectomy in women with unilateral breast cancer: a cancer research network projectJ Clin Oncol2005234275428615795415
   PubMed Web of Science ®Google Scholar
• LostumboLCarbineNEWallaceJProphylactic mastectomy for the prevention of breast cancerCochrane Database Syst RevCD002748
   Web of Science ®Google Scholar
• BedrosianIHuCYChangGJPopulation-based study of contralat-eral prophylactic mastectomy and survival outcomes of breast cancer patientsJ Natl Cancer Inst10240140920185801
   PubMedGoogle Scholar
• OsmanFSalehFJacksonTDCorriganMACilTIncreased postoperative complications in bilateral mastectomy patients compared to unilateral mastectomy: an analysis of the NSQIP databaseAnn Surg Oncol203212321723846780
   PubMed Web of Science ®Google Scholar
• MillerMECzechuraTMartzBOperative risks associated with contralateral prophylactic mastectomy: a single institution experienceAnn Surg Oncol204113412023868655
   PubMed Web of Science ®Google Scholar
• PatelKMBasciDNahabedianMYMultiple pregnancies following deep inferior epigastric perforator (DIEP) flap breast reconstructionJ Plast Reconstr Aesthet Surg6643443622877890
   PubMed Web of Science ®Google Scholar
• BarryMKellMRRadiotherapy and breast reconstruction: a meta-analysisBreast Cancer Res Treat127152221336948
   PubMed Web of Science ®Google Scholar
• DrukkerCABueno-de-MesquitaJMRetelVPA prospective evaluation of a breast cancer prognosis signature in the observational RASTER studyInt J Cancer13392993623371464
   PubMed Web of Science ®Google Scholar
• NguyenMTStessinANagarHImpact of Oncotype DX Recurrence Score in the Management of Breast Cancer CasesClin Breast Cancer1418219024486121
   PubMed Web of Science ®Google Scholar
• Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative GroupLancet19983529309429752815
   PubMed Web of Science ®Google Scholar
• von MinckwitzGEidtmannHRezaiMNeoadjuvant chemotherapy and bevacizumab for HER2-negative breast cancerN Engl J Med36629930922276820
   PubMed Web of Science ®Google Scholar
• WalsheJMDenduluriNSwainSMAmenorrhea in premenopausal women after adjuvant chemotherapy for breast cancerJ Clin Oncol2006245769577917130515
   PubMed Web of Science ®Google Scholar
• SwainSMJeongJHGeyerCEJrLonger therapy, iatrogenic amenorrhea, and survival in early breast cancerN Engl J Med3622053206520519679
   PubMed Web of Science ®Google Scholar
• GoodwinPJEnnisMPritchardKITrudeauMHoodNRisk of menopause during the first year after breast cancer diagnosisJ Clin Oncol1999172365237010561298
   PubMed Web of Science ®Google Scholar
• LeeMCGrayJHanHSPloskerSFertility and reproductive considerations in premenopausal patients with breast cancerCancer Control1716217220664513
   PubMed Web of Science ®Google Scholar
• Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative GroupLancet1998351145114679605801
   PubMed Web of Science ®Google Scholar
• Ovarian ablation in early breast cancer: overview of the randomised trials. Early Breast Cancer Trialists’ Collaborative GroupLancet1996348118911968898035
   PubMed Web of Science ®Google Scholar
• KlijnJGBlameyRWBoccardoFTominagaTDuchateauLSylvesterRCombined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trialsJ Clin Oncol2001193435311208825
   PubMed Web of Science ®Google Scholar
• JonatWKaufmannMSauerbreiWGoserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association StudyJ Clin Oncol2002204628463512488406
   PubMed Web of Science ®Google Scholar
• BernhardJZahriehDCastiglione-GertschMAdjuvant chemotherapy followed by goserelin compared with either modality alone: the impact on amenorrhea, hot flashes, and quality of life in premenopausal patients--the International Breast Cancer Study Group Trial VIIIJ Clin Oncol20072526327017159194
   PubMed Web of Science ®Google Scholar
• Castiglione-GertschMO’NeillAPriceKNAdjuvant chemotherapy followed by goserelin versus either modality alone for premenopausal lymph node-negative breast cancer: a randomized trialJ Natl Cancer Inst2003951833184614679153
   PubMedGoogle Scholar
• von MinckwitzGGrafEGeberthMCMF versus goserelin as adjuvant therapy for node-negative, hormone-receptor-positive breast cancer in premenopausal patients: a randomised trial (GABG trial IV-A-93)Eur J Cancer2006421780178816765589
   PubMed Web of Science ®Google Scholar
• JakeszRHausmaningerHKubistaERandomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian Breast and Colorectal Cancer Study Group Trial 5J Clin Oncol2002204621462712488405
   PubMed Web of Science ®Google Scholar
• GnantMMlineritschBSchippingerWEndocrine therapy plus zoledronic acid in premenopausal breast cancerN Engl J Med200936067969119213681
   PubMed Web of Science ®Google Scholar
• CuzickJAmbroisineLDavidsonNUse of luteinising-hormone-releasing hormone agonists as adjuvant treatment in premenopausal patients with hormone-receptor-positive breast cancer: a meta-analysis of individual patient data from randomised adjuvant trialsLancet20073691711172317512856
   PubMed Web of Science ®Google Scholar
• ZicklL PFFlemingGPaganiOWalleyBPriceKNGelberRDReganMMInternational Breast Cancer Study GroupNorth American Breast Cancer GroupSOFT and TEXT: Trials of tamoxifen and exemestane with and without ovarian function suppression for premenopausal women with hormone receptor-positive early breast cancerCancer Research201272
   Web of Science ®Google Scholar
• RechtAEdgeSBSolinLJPostmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical OncologyJ Clin Oncol2001191539156911230499
   PubMed Web of Science ®Google Scholar
• OvergaardMHansenPSOvergaardJPostoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b TrialN Engl J Med19973379499559395428
   PubMed Web of Science ®Google Scholar
• National Comprehensive Cancer Network Version 22013 http://infoonco.es/wp-content/uploads/2011/10/breast_cancer_2.2013.pdfAccessed June 2014
   Google Scholar
• FreedmanRAVirgoKSLabadieJHeYPartridgeAHKeatingNLReceipt of locoregional therapy among young women with breast cancerBreast Cancer Res Treat13589390622949130
   PubMed Web of Science ®Google Scholar
• QuanMLOsmanFMcCreadyDFernandesKSutradharRPaszatLPostmastectomy radiation and recurrence patterns in breast cancer patients younger than age 35 years: a population-based cohortAnn Surg Oncol2139540024145994
   PubMed Web of Science ®Google Scholar
• BeversTBAndersonBOBonaccioENCCN clinical practice guidelines in oncology: breast cancer screening and diagnosisJ Natl Compr Canc Netw200971060109619930975
   PubMed Web of Science ®Google Scholar
• MaloneKEDalingJRNealCFrequency of BRCA1/BRCA2 mutations in a population-based sample of young breast carcinoma casesCancer2000881393140210717622
   PubMed Web of Science ®Google Scholar
• BroseMSRebbeckTRCalzoneKAStopferJENathansonKLWeberBLCancer risk estimates for BRCA1 mutation carriers identified in a risk evaluation programJ Natl Cancer Inst2002941365137212237282
   PubMed Web of Science ®Google Scholar
• LakhaniSRVan De VijverMJJacquemierJThe pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2J Clin Oncol2002202310231811981002
   PubMed Web of Science ®Google Scholar
• LidereauREisingerFChampemeMHMajor improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancerCancer Res2000601206121010728676
   PubMed Web of Science ®Google Scholar
• SeynaeveCVerhoogLCvan de BoschLMIpsilateral breast tumour recurrence in hereditary breast cancer following breast-conserving therapyEur J Cancer2004401150115815110878
   PubMed Web of Science ®Google Scholar
• HafftyBGHarroldEKhanAJOutcome of conservatively managed early-onset breast cancer by BRCA1/2 statusLancet20023591471147711988246
   PubMed Web of Science ®Google Scholar
• MetcalfeKLynchHTGhadirianPContralateral breast cancer in BRCA1 and BRCA2 mutation carriersJ Clin Oncol2004222328233515197194
   PubMed Web of Science ®Google Scholar
• SmithIEDowsettMYapYSAdjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelinesJ Clin Oncol2006242444244716735701
   PubMed Web of Science ®Google Scholar
• KleihuesPSchaubleBzur HausenAEsteveJOhgakiHTumors associated with p53 germline mutations: a synopsis of 91 familiesAm J Pathol19971501139006316
   PubMed Web of Science ®Google Scholar
• HeXArrottaNRadhakrishnanDWangYRomighTEngCCowden syndrome-related mutations in PTEN associate with enhanced protea-some activityCancer Res733029304023475934
   PubMed Web of Science ®Google Scholar
• SurboneAPetrekJAChildbearing issues in breast carcinoma survivorsCancer199779127112789083146
   PubMed Web of Science ®Google Scholar
• PetrekJANaughtonMJCaseLDIncidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective studyJ Clin Oncol2006241045105116476708
   PubMed Web of Science ®Google Scholar
• LeeSJSchoverLRPartridgeAHAmerican Society of Clinical Oncology recommendations on fertility preservation in cancer patientsJ Clin Oncol2006242917293116651642
   PubMed Web of Science ®Google Scholar
• PartridgeAHGelberSPeppercornJWeb-based survey of fertility issues in young women with breast cancerJ Clin Oncol2004224174418315483028
   PubMed Web of Science ®Google Scholar
• HalleCFMooreJMUKelly-AnnePhillipsBoyleFrances MHitreErikaPorterDavid JamesFrancisPrudence AMinasianLori MGelberRichard DGoldsteinLori JGomezHenry LeonidasVallejosCarlosPartridgeAnn HDakhilShaker RMartinoSilvanaBarlowWilliam EFabianCarol JMeyskensFrank LHortobagyiGabriel NAlbainKathy SPhase III trial (Prevention of Early Menopause Study [POEMS]-SWOG S0230) of LHRH analog during chemotherapy (CT) to reduce ovarian failure in early-stage, hormone receptor-negative breast cancer: An international Intergroup trial of SWOG, IBCSG, ECOG, and CALGB (Alliance)J Clin Oncol325s2014suppl (abstr LBA505) 2014
   Google Scholar
• Del MastroLBoniLMichelottiAEffect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trialJAMA30626927621771987
   PubMed Web of Science ®Google Scholar
• GerberBvon MinckwitzGStehleHEffect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO studyJ Clin Oncol292334234121537042
   PubMed Web of Science ®Google Scholar
• LawrenzBBanysMHenesMNeunhoefferEGrischkeEMFehmTPregnancy after breast cancer: case report and review of the literatureArch Gynecol Obstet28383784321221981
   PubMed Web of Science ®Google Scholar
• LewisLNHickeyMDohertyDASkinnerSRHow do pregnancy outcomes differ in teenage mothers? A Western Australian studyMed J Aust200919053754119450192
   PubMed Web of Science ®Google Scholar
• de BreeEMakrigiannakisAAskoxylakisJMelissasJTsiftsisDDPregnancy after breast cancer. A comprehensive reviewJ Surg Oncol10153454220401921
   PubMed Web of Science ®Google Scholar
• HickeyMPeateMSaundersCMFriedlanderMBreast cancer in young women and its impact on reproductive functionHum Reprod Update20091532333919174449
   PubMed Web of Science ®Google Scholar
• GadducciACosioSGenazzaniAROvarian function and childbearing issues in breast cancer survivorsGynecol Endocrinol20072362563117926162
   PubMed Web of Science ®Google Scholar
• KranickJASchaeferCRowellSIs pregnancy after breast cancer safe?Breast J1640441120522097
   PubMed Web of Science ®Google Scholar
• MuellerBASimonMSDeapenDKamineniAMaloneKEDalingJRChildbearing and survival after breast carcinoma in young womenCancer2003981131114012973836
   PubMed Web of Science ®Google Scholar
• WenzelLBFaircloughDLBradyMJAge-related differences in the quality of life of breast carcinoma patients after treatmentCancer1999861768177410547550
   PubMed Web of Science ®Google Scholar
• BroeckelJAThorsCLJacobsenPBSmallMCoxCESexual functioning in long-term breast cancer survivors treated with adjuvant chemotherapyBreast Cancer Res Treat20027524124812353813
   PubMed Web of Science ®Google Scholar
• GanzPAGreendaleGAPetersenLKahnBBowerJEBreast cancer in younger women: reproductive and late health effects of treatmentJ Clin Oncol2003214184419314615446
   PubMed Web of Science ®Google Scholar
• PhillipsKAOsborneRHGilesGGPsychosocial factors and survival of young women with breast cancer: a population-based prospective cohort studyJ Clin Oncol2008264666467118824713
   PubMed Web of Science ®Google Scholar
• LeeMCBhatiRSvon RottenthalerEETherapy choices and quality of life in young breast cancer survivors: a short-term follow-upAm J Surg20662563124016705
   PubMed Web of Science ®Google Scholar
• SchainWSd’AngeloTMDunnMELichterASPierceLJMastectomy versus conservative surgery and radiation therapy. Psychosocial consequencesCancer199473122112288313326
   PubMed Web of Science ®Google Scholar
• ArndtVStegmaierCZieglerHBrennerHQuality of life over 5 years in women with breast cancer after breast-conserving therapy versus mastectomy: a population-based studyJ Cancer Res Clin Oncol20081341311131818504613
   PubMed Web of Science ®Google Scholar
• WaljeeJFUbelPAAtishaDMHuESAldermanAKThe choice for breast cancer surgery: can women accurately predict postoperative quality of life and disease-related stigma?Ann Surg Oncol182477248221347791
   PubMed Web of Science ®Google Scholar
• TsaiJTHouMFChenYMWanTTKaoHYShiHYPredicting quality of life after breast cancer surgery using ANN-based models: performance comparison with MRSupport Care Cancer211341135023203653
   PubMed Web of Science ®Google Scholar